Tizanidine
Product Images NDC 67296-1599

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 67296-1599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine (Doc20180424130043 001)

Label for Tizanidine HCL 4 mg tablets, containing 15 tablets. The label shows the NDC number 67296-1599-1 and notes that the product is Rx only. It includes a lot number NL9755 1 and expiration date 12/20. The label indicates manufacture by Apotex Inc. in Toronto, Canada, and distribution by RedPharm Drug, Inc. in Eden Prairie, MN. Storage instructions specify controlled room temperature of 20-25°C (68-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.